{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:24:05Z","timestamp":1763400245771,"version":"3.40.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2017YFC1703502"],"award-info":[{"award-number":["2017YFC1703502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,11]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Intracranial atherosclerotic stenosis (ICAS) represents a prevalent global cause of stroke, posing a notably higher risk of stroke recurrence than other stroke etiologies. Herein, we report a case of a 39-year-old male patient diagnosed with ICAS, treated through an integrated approach incorporating Chinese and Western medicine with significant efficacy and satisfied clinical safety.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>This patient presented with 1 transient ischemic attack and prolonged headache, dizziness and poor sleep quality. In addition, the patient refused to undergo surgery due to the high cost and postoperative risks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Diagnostic methods used to identify ICAS include conventional cerebral angiography, magnetic resonance angiography (MRA), CT angiography (CTA), transcranial Doppler ultrasound (TCD), and High-Resolution Magnetic resonance imaging. Considering the cost and risks associated with conventional angiography, noninvasive imaging has emerged as the method of choice for diagnosing ICAS. After a series of noninvasive examinations (CTA, TCD, and HR-MRI), the patient was diagnosed with ICAS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The western medical regimen includes antiplatelet coagulation, blood pressure control, lipid regulation, plaque stabilization, and lifestyle modifications such as exercise, weight loss, and adherence to low-salt, low-fat diets. Complementing this, traditional Chinese medicine (TCM) treatment was guided by the principle of strengthening the spleen, resolving dampness, nourishing blood and harmonizing ying, resolving blood stasis and clearing collaterals. This involved the administration oral Chinese medicine such as modified Shenling Baizhu powder and modified Si Wu decoction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The efficacy of the treatment was assessed by evaluating the degree of luminal stenosis and peak systolic blood flow velocity in the M1 segment of the left middle cerebral artery (MCA) before and after the intervention. Encouragingly, posttreatment results demonstrated the disappearance of the plaque in the left MCA-M1 segment, with no significant lumen stenosis observed. Moreover, a notable and smooth reduction in blood flow velocity was achieved in the left MCA, indicating positive outcomes from the integrated traditional Chinese and Western medicine approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This case report shows that a combination of traditional Chinese and Western medicine is safe and effective in the treatment of ICAS and is worthy of promotion in the clinic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040055","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T18:01:38Z","timestamp":1728928898000},"page":"e40055","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A case report of effective treatment of intracranial atherosclerotic stenosis treated with the integration of traditional Chinese medicine and Western medicine"],"prefix":"10.1097","volume":"103","author":[{"given":"Wen-Wen","family":"Hu","sequence":"first","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine (BUCM), Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiran","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Ke","family":"Cai","sequence":"additional","affiliation":[{"name":"School of Chinese materia medica, Beijing University of Chinese Medicine (BUCM), Fangshan District, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Beijing University of Chinese Medicine (BUCM), Fangshan District, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Guang","family":"Chen","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine (BUCM), Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3461-590X","authenticated-orcid":false,"given":"Li-Qun","family":"Zhong","sequence":"additional","affiliation":[{"name":"Dongzhimen Hospital, Beijing University of Chinese Medicine (BUCM), Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(21)00376-8","article-title":"Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment.","volume":"21","author":"Gutierrez","year":"2022","journal-title":"Lancet Neurol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0b013e31828ab2ed","article-title":"Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients.","volume":"80","author":"Von Sarnowski","year":"2013","journal-title":"Neurology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/STROKEAHA.113.003508","article-title":"Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese intracranial atherosclerosis (CICAS) study.","volume":"45","author":"Wang","year":"2014","journal-title":"Stroke"},{"key":"R4-20250504","first-page":"272","article-title":"Summary of the China stroke prevention and control report 2019.","volume":"17","year":"2020","journal-title":"Chin J Cerebrovasc Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000003837","article-title":"Intracranial atherosclerosis and dementia: the atherosclerosis risk in communities (ARIC) study.","volume":"88","author":"Dearborn","year":"2017","journal-title":"Neurology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1590\/0004-282x20180095","article-title":"Stroke recurrence in the different subtypes of ischemic stroke. The importance of the intracranial disease.","volume":"76","author":"Lange","year":"2018","journal-title":"Arq Neuropsiquiatr"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1105335","article-title":"Stenting versus aggressive medical therapy for intracranial arterial stenosis.","volume":"365","author":"Chimowitz","year":"2011","journal-title":"N Engl J Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2015.1693","article-title":"Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.","volume":"313","author":"Zaidat","year":"2015","journal-title":"JAMA"},{"key":"R9-20250504","first-page":"1","article-title":"Effects of stent shape on focal hemodynamics in intracranial atherosclerotic stenosis: a simulation study with computational fluid dynamics modeling.","volume":"13","author":"Haipeng","year":"2022","journal-title":"Front Neurol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.0000000000003534","article-title":"Relationship between risk factor control and vascular events in the SAMMPRIS trial.","volume":"88","author":"Turan","year":"2017","journal-title":"Neurology"},{"key":"R11-20250504","first-page":"e2988","article-title":"Percutaneous transluminal angioplasty with stent placement versus best medical therapy alone in symptomatic intracranial arterial stenosis: a best evidence review.","volume":"10","author":"Padalia","year":"2018","journal-title":"Cureus"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/01.STR.26.1.14","article-title":"Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan stroke study.","volume":"26","author":"Sacco","year":"1995","journal-title":"Stroke"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/STROKEAHA.115.011292","article-title":"Prevalence of intracranial atherosclerotic stenosis using high-resolution magnetic resonance angiography in the general population: the atherosclerosis risk in communities study.","volume":"47","author":"Suri","year":"2016","journal-title":"Stroke"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/01.wnl.0000279338.18776.26","article-title":"Risk factor status and vascular events in patients with symptomatic intracranial stenosis.","volume":"69","author":"Chaturvedi","year":"2007","journal-title":"Neurology"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jacc.2021.05.041","article-title":"Determinants and outcomes of asymptomatic intracranial atherosclerotic stenosis.","volume":"78","author":"Gutierrez","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/STROKEAHA.110.584672","article-title":"Risk factors associated with severity and location of intracranial arterial stenosis.","volume":"41","author":"Turan","year":"2010","journal-title":"Stroke"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4757-4820-8_25","article-title":"Earthworms: sources of antimicrobial and anticancer molecules.","volume":"546","author":"Cooper","year":"2004","journal-title":"Adv Exp Med Biol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.3760\/cma.j.issn.0366-6999.20131332","article-title":"Oral fibrinogen depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial.","volume":"126","author":"Cao","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejphar.2008.05.037","article-title":"Mechanisms of lumbrokinase in protection of cerebral ischemia.","volume":"590","author":"Ji","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R20-20250504","first-page":"213","article-title":"Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.","volume":"23","author":"Jin","year":"2000","journal-title":"Clin Hemorheol Microcirc"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1142\/S0192415X14500943","article-title":"Dilong prevents the high-KCl cardioplegic solution administration-induced apoptosis in H9c2 cardiomyoblast cells mediated by MEK.","volume":"42","author":"Han","year":"2014","journal-title":"Am J Chin Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.yjmcc.2016.08.004","article-title":"Lumbrokinase attenuates myocardial ischemia-reperfusion injury by inhibiting TLR4 signaling.","volume":"99","author":"Wang","year":"2016","journal-title":"J Mol Cell Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:20:12Z","timestamp":1746321612000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":22,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040055","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,10,11]]}}}